Venous Stasis Ulcer
15
3
3
5
Key Insights
Highlights
Success Rate
56% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
26.7%
4 terminated out of 15 trials
55.6%
-31.0% vs benchmark
27%
4 trials in Phase 3/4
120%
6 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (15)
MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers
Tissue Repair Gel in Venous Leg Ulcers (US)
Tissue Repair Gel in Venous Leg Ulcers in AU/US
A Multi-center, Prospective, Randomized Study With PriMatrix and PriMatrix Ag for the Treatment of Venous Leg Ulcers
SkinTE® in the Treatment of Venous Leg Wounds
Cooling Leg and Foot Ulcer Skin Post Healing to Prevent Ulcer Recurrence
Cellular and Tissue Based Therapy Registry
Negative Pressure Wound Therapy Registry
Venous Leg Ulcer and Lymphedema Registry
Safety Follow-Up to HP 802-247-09-015
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers (VLUs)
Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers
Efficacy Study of the Application of Low Level Laser Light to Treat Venous Stasis Ulcers
Flexitouch Compression System for Venous Stasis Ulcer
Evaluation of Bilayered Cellular Matrix (OrCel) for the Treatment of Venous Ulcers